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Abstract
Background: Depletion of T cells following infection by Mycobacterium tuberculosis (Mtb) impairs disease resolution, and
interferes with clinical test performance that relies on cell-mediated immunity. A number of mechanisms contribute to this T
cell suppression, such as activation-induced death and trafficking of T cells out of the peripheral circulation and into the
diseased lungs. The extent to which Mtb infection of human macrophages affects T cell viability however, is not well
characterised.
Methodology/Principal Findings: We found that lymphopenia (,1.5610
9 cells/l) was prevalent among culture-positive
tuberculosis patients, and lymphocyte counts significantly improved post-therapy. We previously reported that Mtb-
infected human macrophages resulted in death of infected and uninfected bystander macrophages. In the current study,
we sought to examine the influence of infected human alveolar macrophages on T cells. We infected primary human
alveolar macrophages (the primary host cell for Mtb) or PMA-differentiated THP-1 cells with Mtb H37Ra, then prepared cell-
free supernatants. The supernatants of Mtb-infected macrophages caused dose-dependent, caspase-dependent, T cell
apoptosis. This toxic effect of infected macrophage secreted factors did not require TNF-a or Fas. The supernatant cytotoxic
signal(s) were heat-labile and greater than 50 kDa in molecular size. Although ESAT-6 was toxic to T cells, other Mtb-
secreted factors tested did not influence T cell viability; nor did macrophage-free Mtb bacilli or broth from Mtb cultures.
Furthermore, supernatants from Mycobacterium bovis Bacille de Calmette et Guerin (BCG)- infected macrophages also
elicited T cell death suggesting that ESAT-6 itself, although cytotoxic, was not the principal mediator of T cell death in our
system.
Conclusions: Mtb-Infected macrophages secrete heat-labile factors that are toxic to T cells, and may contribute to the
immunosuppression seen in tuberculosis as well as interfere with microbial eradication in the granuloma.
Citation: Macdonald SH-F, Woodward E, Coleman MM, Dorris ER, Nadarajan P, et al. (2012) Networked T Cell Death following Macrophage Infection by
Mycobacterium tuberculosis. PLoS ONE 7(6): e38488. doi:10.1371/journal.pone.0038488
Editor: Pere-Joan Cardona, Fundacio ´ Institut d’Investigacio ´ en Cie `ncies de la Salut Germans Trias i Pujol. Universitat Auto `noma de Barcelona. Ciberes, Spain
Received September 7, 2011; Accepted May 6, 2012; Published June 4, 2012
Copyright:  2012 Macdonald et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Science Foundation Ireland (SFI; www.sfi.ie) and the Health Research Board (HRB; www.hrb.ie). JK, SHFM and MMC were
supported by SFI as part of the Immunology Research Centre, (SFI) Strategic Research Cluster grant (07/SRC/B1144 Cluster Grant E02209420). ERD was funded by
the HRB’s PhD Scholars’ Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: macdonaldez@gmail.com
Introduction
Tuberculosis (TB) in an immunosuppressive illness and
lymphopenia often occurs in TB patients [1,2]. Rather than being
an epiphenomenon, it is more likely that this T cell deficiency
contributes to pathogen persistence in the host, and the lack of a
meaningful immune response during chronic TB infection.
Indeed, intracellular pathogens such as Mycobacterium tuberculosis
(Mtb) must suppress immunity to survive within an infected host
[3,4], and the status of host T lymphocytes is a critical factor in
determining the resolution of chronic infections, like tuberculosis.
The mechanism of lymphopenia in tuberculosis patients is poorly
understood, but may involve activation-induced apoptosis or
sequestration of lymphocytes to inflamed organs such as the lung.
T cells enhance the activity of phagocytes against Mtb and other
intracellular microbes by delivering activating signals, including
interferon-c (IFN-c) [5], subsequently upregulating key processes
such as nitric oxide generation and apoptosis [6,7]. Accordingly,
the significant T cell depletion which accompanies active TB
disease is associated with poor prognosis [1,8] as well as
diminished cytokine responses which may persist even following
successful antitubercular therapy [9]. T cell apoptosis is also an
abundant feature of the granuloma, which is a highly organised
structure comprising a necrotic centre containing bacteria, dead
and infected macrophages, as well as multinucleate giant cells,
surrounded by a peripheral cuff of lymphocytes [10,11]. Host
phagocyte death can be inhibited by Mtb [12], and it has been
shown, by Mustafa et al., that infected cells at the granuloma centre
express reduced levels of apoptotic markers such as caspase 3 than
those that are uninfected [13]. However significant levels of
proapoptotic surface molecules such as Fas ligand are expressed at
the periphery of the granuloma, where T cells accumulate [14].
This may represent an infection-induced ‘keep out’ signal that
prevents T cell penetration into the granuloma centre. Addition-
ally, Hirsch et al. have described an increased susceptibility to
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research by Sharma et al. indicated that infected macrophages can
signal T cell apoptosis [16]. The mechanism of this T cell death
response is unclear, and it is not known if Mtb-infected human
alveolar macrophages (AMs) can supply this immunosuppressive
death signal.
We found that lymphopenia was prevalent in our culture
positive tuberculosis patients, and there was a statistically
significant recovery of lymphocyte counts after anti-TB treatment.
Because animal model work had associated low lymphocyte counts
with death following mycobacterial infection [17], we sought to
investigate the toxic effect of infected macrophages on T cells. We
have previously reported that human alveolar macrophage
infection by Mtb can elicit signals that kill infected cells and
nearby uninfected bystander macrophages, in what is likely a host-
protective response. The macrophage death response deprives the
bacilli of their replicative niche cell and facilitates delivery of
mycobacterial antigens to APCs, enabling antigen presentation
[18,19]. Even as the infected human alveolar macrophage death
response may support TB immunity, it is likely that a death signal
delivered to nearby T cells would diminish the host response
[12,20]. We now report that Mtb-infected human alveolar
macrophages do cause networked, caspase-dependent lymphocyte
apoptosis. Like alveolar macrophages, cell-free culture superna-
tants from Mtb-infected THP-1 macrophages reliably induced this
T cell killing phenotype. We found that this human macrophage
cell line recapitulates this host response to infection, which is dose-
dependent, but TNF-a and Fas-independent. We show that
macrophage-free Mtb bacilli are not sufficient to signal T cell
death, which suggests a role for a PAMP/DAMP complex derived
from infected cells. Thus far, we have begun to characterise the T
cell death-inducing signal secreted from infected macrophages,
and found it to be heat-labile and greater than 50 kDa in
molecular size.
Methods
Ethics Statement
For patient lymphocyte counts, all analysis was performed
anonymously on preexisting clinical data, therefore consent was
not required. For alveolar macrophage isolation, informed written
consent was obtained as part of the project ‘‘Airway gene
expression profiling and immune response to lung disease’’,
approved by the St. James’s Hospital/AMNCH Research Ethics
Committee. Only the ‘‘Immune Response to Lung Disease’’ aspect
of the ethics approval was used in this manuscript.
Reagents and Antibodies
Except where specified, all reagents and materials were
obtained from Sigma-Aldrich. Anti-human TNF-a blocking
antibody (cat# MAB210) and mouse IgG1 isotype control (cat#
MAB002) were obtained from R&D systems. Anti-human Fas
blocking antibody ZB-4 (cat# 05-338) was obtained from
Millipore. Mtb secreted factors 16 kDa (cat# NR-14860),
45 kDa (cat# NR-14862), Antigen85 (cat# NR-14855), ESAT-6
(cat# NR-14868), GroES (cat# NR-14861), ManLAM (cat#
NR-14848) and Phos1 (cat# NR-14859) were obtained from BEI
resources, NIAID, NIH under the TB Vaccine Testing and
Research Materials (TBVTRM) contract no.
HHSN266200400091C awarded to Colorado State University.
Patient Lymphocyte Counts
All analysis of patient data was carried out anonymously. We
performed a retrospective analysis of lymphocyte counts of
twenty Mtb-culture positive patients recruited consecutively
from our TB service at St James’ Hospital, starting November
2009. Pre-treatment lymphocyte counts were performed on the
date of diagnosis prior to initiating anti-tuberculous treatment
and post treatment lymphocyte counts were performed after at
least 2 months of treatment. Lymphopenia was defined as a
lymphocyte count of less than 1.5610
9/l. Immunosupressed
patients (e.g. HIV-positive, steroid use) and cancer patients were
excluded.
Culture of Mycobacterium Tuberculosis
M.tuberculosis H37Ra and M.bovis BCG, obtained from ATCC,
were grown to log phase at 37uCi n5 %C O 2 in Middlebrook 7H9
broth (Difco), supplemented with albumin-dextrose-catalase (Bec-
ton Dickinson) and 0.05% Tween-80 (Difco), and made up in
endotoxin-free water.
Isolation of Primary Human Alveolar Macrophages
Human alveolar macrophages were obtained at bronchosco-
py, after written consent, under a protocol approved by the St.
James’s Hospital/AMNCH ethics board. Cells in bronchoalve-
olar lavage fluid were passed through a 100 mm nylon cell
strainer (BD Bioscience), then centrifuged for 156min at 2006g
and subsequently resuspended in RPMI supplemented with 10%
human serum, 0.2% Fungizone, and 0.1% Cefotaxime. AMs
were then seeded onto tissue culture plates at a density of
5610
5 cells per ml, and incubated overnight at 37uCi n5 %
CO2 before use.
Figure 1. Patient lymphocyte counts pre- and post antituber-
cular chemotherapy. Lymphocyte counts were taken, before and
after treatment, from twenty patients who were culture-positive for
Mtb. Each joined pair of data points represents pre- and post-therapy
lymphocyte counts (610
9 cells/l) from a single patient. Data from
patients whose lymphocyte counts recovered following treatment are
shown in black; counts from patients whose lymphocyte counts fell or
did not change are shown in grey. **= p,0.01, paired Student’s t test
comparing pre-treatment vs post-treatment counts.
doi:10.1371/journal.pone.0038488.g001
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Cells of the human T cell leukaemia line, Jurkat (ATCC #TIB-
152), and the monocytic leukaemia line, THP-1 (ATCC #TIB-
202) were routinely cultured at 37uCi n5 %C O 2 in RPMI 1640,
supplemented with 10% FBS (hereafter referred to as ‘complete
RPMI’), at a density of between 1610
521610
6 and
2610
528610
5 cells/ml respectively.
Isolation of Primary Human Peripheral Blood
T lymphocytes (PBTL)
Lymphocytes were isolated from human whole blood provided
by the Irish Blood Transfusion Service. Briefly, blood was diluted
1:2 with sterile PBS, then layered onto lymphoprep and spun at
12006g without brake for 20 min at room temperature. Buffy
coats were removed, and then washed three times with PBS. Cells
were then resuspended in serum-free RPMI, and incubated for 2 h
at 37uCi n5 %C O 2 to remove monocytes. Nonadherent cells were
then harvested and resuspended in complete RPMI +2 mg/ml
PHA and incubated for 3 days at 37uCi n5 %C O 2. Subsequently,
cells were washed in complete RPMI and resuspended at a density
of 1.5610
6 cells/ml in complete RPMI supplemented with 20 ng/
ml IL-2 (Peprotech), then incubated for 5 days at 37uCi n5 %C O 2
to generate PBTLs.
M. tuberculosis Infection of Macrophages
M.tuberculosis H37Ra or M.bovis BCG bacilli growing in the log
phase were centrifuged at 30006g for 10 min, and then
resuspended in complete RPMI. This suspension was then passed
8 times through a 25 G needle, before centrifugation at 1006g for
3 min to remove remaining clumped bacteria. Bacterial suspen-
sion was then transferred to a fresh tube, and subsequently used for
infection of AMs prepared as described above, or THP-1 cells,
previously differentiated to a macrophage phenotype by 72 h
incubation with 100 nM Phorbol 12-myristate 13-acetate (PMA).
Cells were infected with a range of volumes of Mtb H37Ra or
BCG suspension, then following 3 h incubation, remaining
extracellular bacilli were washed off with PBS, and cells were
fixed with 2% paraformaldehyde in PBS for 5 min, and
subsequently stained using a Rapid Modified Auramine O Stain
Set (Scientific Device Laboratory Inc.) according to the manufac-
turer’s protocol, followed by 5 min staining with 10 mg/ml
Hoechst 33258. Cells were imaged using fluorescent microscopy
in order to determine the Multiplicity of Infection (MOI), where a
low MOI was defined as .70% of cells infected with 1–5 bacteria,
and a high MOI as .80% of cells infected with 6–10 bacteria.
Subsequently, AMs at a density of 5610
5 cells/ml or THP-1
macrophages growing at a density of 5610
4 cells/ml in tissue
culture plates, were infected in this manner, incubated for 3 h,
then remaining extracellular bacilli were washed off and infected
cells were incubated for a further 48 h in complete RPMI. For
uninfected controls, cells were processed in parallel, but without
addition of bacilli. Following this incubation, supernatants were
removed from the cells, then centrifuged at 6,8006g to remove
any free bacteria, and stored at 220uC.
T Cell Culture in Cell-free Supernatants from Mtb-
infected Macrophages
Jurkat T cells or PBTLs were incubated in 96-well plates at a
density of 1610
4 cells/well, in triplicate, in a volume of 150 ml/
well, in cell-free supernatants from Mtb- or BCG- infected
macrophages. 1 mM Staurosporine was used as a positive control
for cell death. Following 24 h incubation, cells were stained
simultaneously with 5 mg/ml Propidium Iodide (PI), 20 mg/ml
Hoechst 33342 and 50 mg/ml Hoechst 33258, briefly resuspended
by gentle pipetting, then plates were centrifuged at 4006g for
2 min to bring cells in suspension to the bottom surface of the well.
Plates were then imaged using an INCell Analyzer 1000 cellular
imaging system (GE Healthcare) and images were analyzed using
GE INCell Analyzer 1000 Workstation software version 3.6 (GE
Healthcare) as we have previously published [21]. Total cell
numbers were detected via Hoechst staining of nuclei, and the
dying/dead cells were identified via positivity for PI staining and/
or nuclear condensation, which was characterised by elevated
intensity of Hoechst staining within the nuclei (see figure S1). 12–
18 fields of view per well were acquired.
M. tuberculosis/T Cell Coculture, Supernatant and
Secreted Antigen Experiments
For coincubation experiments, Mtb H37Ra bacilli growing in
the log phase were incubated in 96-well plates with T cells at
varying ratios, with a constant 1610
4 cells per well in triplicate,
then imaged with Hoechst/PI staining as before. T cells were also
incubated in triplicate in 96-well plates at 1610
4 cells per well for
24 h in increasing dilutions of cleared culture supernatant taken
from Mtb growing in the log phase in free culture, and then
imaged. For secreted antigen experiments, T cells were incubated
in the same manner, in logarithmic dilutions of each antigen in a
concentration range of 10 mg/ml to 0.1 mg/ml, for 24 h before
imaging.
Manipulation of Infected Macrophage Supernatants
For blocking antibody experiments, anti-human TNF-a (here-
after referred to as anti-hTNF-a)( 5 mg/ml), anti-human Fas
(hereafter referred to as anti-Fas) (2.5 mg/ml) or isotype control
IgG at the same concentration were added to supernatants, and
incubations carried out as described above. In positive control
experiments for TNF-mediated cell killing, cells were incubated for
15 min in the presence of 0.2 mg/ml cycloheximide, then
recombinant human TNF-a (R&D Systems) was added to 5 ng/
ml. In positive control experiments for Fas ligand-mediated cell
killing, cells were incubated in the presence of 10 ng/ml
recombinant human Fas ligand (R&D systems), crosslinked with
10 mg/ml anti-66Histidine (R&D systems).
Figure 2. M.tuberculosis-infected macrophage supernatants are toxic to T cells. (A) Jurkat T cells underwent significantly increased cell
death in cell-free supernatants of low MOI and high MOI Mtb-infected human primary alveolar macrophages (AMs) (shaded bars; infection + and ++,
respectively), compared to those of uninfected AMs (closed bars, infection –). Staurosporine 1 mM was used as a positive control to induce cell death
(open bars). Similar effects were observed on PBTL and Jurkat T cells exposed to the cell-free supernatants of uninfected/infected THP-1
macrophages. (B) Jurkat cell death in infected THP-1 macrophage supernatant occurred in a dose-dependent manner; infected macrophage
supernatants were diluted to 50% and 20% in uninfected supernatant, reducing the level of T cell killing. (C) Example cropped fluorescence intensity
images for Hoechst and PI staining from Jurkats incubated in uninfected and infected AM supernatants. Images were processed using automated
INCell image analysis to detect apoptotic condensed and fragmented nuclei (arrow 1 and 2, respectively) and PI-positive cells (arrow head). Data in
each panel are from one representative experiment, showing mean percentage cell death 6 SEM from incubations performed in triplicate. **=
p,0.01, ***= p,0.001, Student’s t test relative to uninfected control.
doi:10.1371/journal.pone.0038488.g002
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95uC for 20 min, and then allowed to cool to room temperature
before use. Initial experiments (data not shown) indicated that to
preserve normal T cell viability, medium heated in this manner
requires subsequent resupplementation with 10% FBS, therefore
all supernatants were resupplemented following heat treatment.
For molecular weight cutoff experiments, supernatants were
spun on Amicon Ultra-15 centrifugal filter units with Ultracel-50
membrane (Millipore), then filtrate (hereafter referred to as
,50 kDa fraction) and retentate (hereafter referred to as
.50 kDa fraction) recovered. During optimisation experiments
(data not shown), the .50 kDa fractions were found to affect the
basal levels of cell death when applied to T cells, due to
concentration of soluble factors from the medium itself, therefore
fractions were diluted to 25% or 10% in fresh medium for
subsequent experiments.
Statistical Analysis
In data from patients who underwent antitubercular chemo-
therapy, a two-tailed, paired Student’s t test was used in Microsoft
Excel to determine significance between pre- and post-treatment
lymphocyte counts. In all other cases, experiments were carried
out in triplicate, and were performed a minimum of three times,
except where specifically stated otherwise, with representative data
from one experiment shown in each figure. Results were expressed
as mean 6 SEM, and statistical analysis was performed using a
two-tailed, unpaired Student’s t test in Microsoft Excel. A p-value
of less than 0.05 was considered to be statistically-significant.
Results
Lymphopenia is Prevalent in Tuberculosis Patients and
Recovers after Treatment
We assessed the lymphocyte counts of twenty consecutively
recruited patients who were culture-positive for Mtb infection,
sampled before and after antitubercular chemotherapy. Low levels
of lymphocytes (,1.5610
9/l in 13 out of 20 cases) were prevalent
at presentation, but significantly improved after treatment
(p,0.01) (fig. 1). This suggests that primary lymphopenia is not
the reason for tuberculosis reactivation in this group. It does
however link infection burden and inadequate lymphocytes [22].
We then investigated the signaling factors released from Mtb-
infected human macrophages that contribute to this clinical
phenotype, of lymphocyte death.
M. tuberculosis Infection of Primary Human Alveolar
Macrophages Signals T Cell Death
To investigate whether soluble mediators released during Mtb
infection could alter the viability of T cells in a contact-
independent manner, we first infected primary human alveolar
macrophages for 48 h with Mtb H37Ra bacilli, then harvested
culture supernatants and applied them to Jurkat T cells for 24 h
before assessing cell death. In Jurkats incubated in cell-free
Figure 3. Macrophage-free M.tuberculosis bacilli are not suffi-
cient to induce T cell death. PBTLs (A) and Jurkat T cells (B) were
incubated either in complete RPMI only (closed bars) or coincubated
with Mtb bacilli at a range of T cell: Mtb ratios (shaded bars).
Subsequently, Jurkat T cells were incubated in complete RPMI
supplemented with medium taken from Mtb growing in the log phase
at a range of ratios (shaded bars) (C). Staurosporine 1 mM was used as a
positive control to induce cell death. Data in each panel are from one
representative experiment, showing mean percentage cell death 6 SEM
from incubations performed in triplicate. ***= p,0.001, Student’s t test
relative to uninfected control.
doi:10.1371/journal.pone.0038488.g003
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observed, whereas in supernatants from low and high MOI Mtb-
infected AMs, this increased significantly (p,0.001) to
18.1260.24% and 21.1360.25%, respectively. 1 mM Staurospor-
ine used as a positive cell-killing control caused 67.3360.85%
death (fig. 2A). In this, and subsequent experiments, an automated
image analysis strategy (figure S1) was used to clearly identify
apoptotic cells that had condensed/fragmented nuclei and/or PI
staining, and discriminate them from live cells (fig. 2C).
In the past, we have found that PMA-treated THP-1 human
macrophages serve as a good model for the human alveolar
macrophage, with respect to innate responses after infection with
Mtb. Specifically we have shown that the host responses of
infection-induced macrophage apoptosis and phagolysosomal
maturation arrest are well reproduced in this cell-line [23,24].
To test whether PMA-treated THP-1 cells could be used as a
model human macrophage to study the mechanism of networked
T cell death, we investigated the toxic effect of infected THP-1
macrophage supernatants on T cells. Peripheral blood T lympho-
cytes were incubated for 24 h in supernatants from Mtb-infected
THP-1 macrophages, or supernatants from uninfected macro-
phages as controls. 15.3360.60% cell death occurred in PBTLs
exposed to uninfected supernatants, whilst in those incubated in
low and high MOI supernatants, this increased significantly to
28.8060.41% and 28.8161.53% (p,0.001 and 0.01), respectively
(fig. 2A). In order to investigate whether PBTLs could be replaced
with a cell line in further studies, we repeated this experiment
using the Jurkat T cell line as a death signal target. In Jurkat cells
cultured in supernatants from uninfected THP-1 macrophages,
9.5760.03% cell death was observed following incubation,
whereas in cells cultured in low MOI and high MOI-infected
macrophage supernatants, significantly (p,0.001) enhanced cell
death was observed, with percentage dead cells increasing to
23.3360.60% and 25.6860.69% respectively (fig. 2A). Stauros-
porine was used routinely as a positive control, and significantly
(p,0.001) increased cell death to 68.4560.57% and
72.6161.41% in PBTLs and Jurkats, respectively.
T Cell Killing by Infected Macrophage Supernatants is
Dose-dependent
To confirm that soluble mediators contained in the medium of
infected macrophages were responsible for T cell death, we carried
out a dose-response assay using infected supernatants. In
uninfected control THP-1 supernatants, 6.1160.36% Jurkat T
cell death was observed. This was significantly (p,0.001) elevated
in undiluted, high MOI-infected THP-1 supernatant, to
17.2360.49%, and progressively reduced to 10.8860.45% at a
50% dilution, and 9.4960.42% at a 20% dilution, both of which
were also significantly (p,0.01) higher than the uninfected control
(fig. 2B).
Macrophage-free M. tuberculosis Bacilli are not Sufficient
to Signal T Cell Death
Mtb bacilli alone, and without macrophages, were insufficient to
cause toxicity to T cells; in PBTLs coincubated for 24 h with live
bacilli at 1:1, 1:5 and 1:10 ratios; 12.8960.94%, 11.7261.55%
and 12.0160.34% cell death was observed, respectively, and none
of these was significantly higher than the medium-only control,
where 9.2160.36% cell death occurred (fig. 3A). This result was
also seen in Jurkats coincubated for 24 h with live bacilli at 1:1, 1:5
and 1:10 ratios; 6.5060.28%, 4.6260.34 and 5.8260.57% cell
death was observed, and again this was not significantly higher
than in cells incubated in the absence of Mtb, where 3.7760.38%
death was observed (fig. 3B). Culture medium from Mtb H37Ra
growing in the log phase was also applied Jurkat T cells, in order to
investigate whether factors released during normal growth of the
bacilli in culture broth could perturb viability. No significant
increase was observed in cells incubated in complete RPMI
supplemented with 10, 25 or 50% of Mtb-conditioned medium;
1.9360.12%, 2.0560.07% and 4.3760.88% cell death was
observed, respectively, whilst 2.8660.22% was observed in the
unsupplemented control. 1 mM staurosporine induced significantly
(p,0.001) enhanced cell death, at 58.5360.18% (fig. 3C).
T Cell Death Mediated by Secreted Antigens of
M. tuberculosis
To examine whether T cell death in our system was attributable
to other specific secreted proteins from Mtb, and since such
secreted factors have previously been shown to alter immune cell
survival [25,26,27] and activity [28], we exposed Jurkat cells to a
panel of Mtb-derived factors. In Jurkat cells incubated in the
presence of ESAT-6 at concentrations of 10 mg/ml, 1 mg/ml and
0.1 mg/ml, 58.3360.58%, 12.4360.55% and 7.0460.23% cell
death was observed. At 10 mg/ml and 1 mg/ml, cell death was
significantly (P,0.001) elevated above that of the vehicle control,
where 6.3560.16% death was observed. Staurosporine 1 mM was
used as a positive cell killing stimulus, and induced 64.6361.34%
death. Elevated death was not observed in T cells incubated with
other secreted antigens such as 16 kDa, 45 kDa, Antigen 85
complex, GroES, ManLAM or Phos1 (fig. 4A–G). To examine
whether ESAT-6 could be the principal mediator of T cell death in
our system, we performed AM infections using Mtb H37Ra in
parallel with M.bovis BCG, then cultured Jurkat T cells in the
resulting cell-free supernatants as described previously. In unin-
fected AM supernatants, T cell death was 9.5660.22%; this
significantly increased to 14.3961.38% (p,0.05) and
18.3060.31% (p,0.001) in low and high MOI H37Ra-infected
AM supernatants, respectively. In low and high MOI BCG-
infected AM supernatants, T cell death also increased significantly
(p,0.01) to 12.3860.52% and 17.160.91%, respectively (fig. 4H).
No significant difference was found when T cell death in H37Ra-
infected AM supernatants at low or high MOI was compared with
that in BCG-infected AM supernatants at the same MOIs.
Cell Death Induction by Infected Macrophage
Supernatants is Caspase-dependent, but not Mediated
by TNF-a or Fas
To further delineate the factors responsible for T cell killing in
macrophage conditioned medium, a number of blocking strategies
were employed. Firstly, addition of the pan-caspase inhibitor, Z-
Figure 4. T cell death after exposure to M.tuberculosis secreted antigens. Jurkat T cells were exposed for 24 h to a panel of secreted factors
derived from Mtb. No increase in cell death occurred when T cells were incubated with 16 kDa, 45 kDa, Antigen 85 complex, GroES, ManLAM or
Phos1 (A–C, E–G, respectively, shaded bars), however elevated death occurred in cells incubated with ESAT-6 at 10 mg/ml or 1 mg/ml (D). 1 mM
Staurosporine was used as a positive control in each case (open bars); vehicle control was either PBS or DMSO in the case of ManLAM (closed bars).
Supernatants of AMs infected with H37Ra or M.bovis BCG both significantly increased T cell death (H, shaded bars), compared with uninfected AM
supernatants (H, closed bars). Data in each panel are from one representative experiment, showing mean percentage cell death 6 SEM from
incubations performed in triplicate. *= p,0.05, **= p,0.01, ***= p,0.001, Student’s t test relative to vehicle (A–G) or uninfected (H) control.
doi:10.1371/journal.pone.0038488.g004
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incubation with T cells attenuated cell death, indicating that the
effect was caspase-dependent. In cells incubated without inhibitor,
cell death in medium from uninfected macrophages was
13.6660.45%, which increased significantly (p,0.001) to
24.3960.61% and 25.0760.81% in low MOI and high MOI
supernatants respectively. Following incubation in the same
supernatants after addition of 20 mM Z-VAD-FMK, cell death
was 2.0160.19%, 1.8860.03% and 2.5660.03% in uninfected,
low MOI and high MOI supernatants, respectively (fig. 5A). In
Figure 5. T cell death in M.tuberculosis-infected macrophage supernatants is caspase-dependent, and independent of TNF-a and
Fas. (A) Addition of the pan-caspase inhibitor Z-VAD-FMK mitigated cell death induced by low MOI and high MOI-infected macrophage supernatants
(shaded bars, infection + and ++ respectively), as well as background cell death observed in the uninfected control supernatants (closed bars,
infection -). Cell death in infected supernatants was not mitigated by coincubation with blocking antibodies to TNF-a (B) or Fas (C), and in each case
was significantly higher than in uninfected control supernatants (closed bars). Cell death induced by positive controls (D) (1 mM Staurosporine, 5 ng/
ml recombinant human TNF-a +0.2 mg/ml cycloheximide and 10 ng/ml recombinant human Fas ligand) was in each case significantly reduced by
coincubation with the corresponding inhibitor (open bars). Data shown in each panel are from one representative experiment, showing mean
percentage cell death 6 SEM from triplicate incubations. **= p,0.01, ***= p,0.001, Student’s t test relative to uninfected control (A–C), or positive
control relative to inhibitor (D).
doi:10.1371/journal.pone.0038488.g005
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death, which was significantly (p,0.001) mitigated by coincuba-
tion with 20 mM Z-VAD-FMK, to 28.1461.35% (fig. 5D).
Secondly, supernatants from infected macrophages were
applied to T cells in the presence of TNF-a blocking antibody,
at a concentration of 5 mg/ml, or isotype IgG at the same
Figure 6. T cell death in M.tuberculosis-infected macrophage culture supernatants is mediated by heat-sensitive factor(s) greater
than 50 kDa in molecular size. (A) Heat inactivation (95uC, 20 min) of supernatants from low MOI and high MOI-infected macrophages (shaded
bars, infection + and ++ respectively) inhibited induction of Jurkat T cell death. (B) Death-inducing factor(s) in infected macrophage supernatants
were retained in the .50 kDa fractions following molecular size separation, and killed Jurkat T cells in a dose-dependent manner (25% and 10%
dilution). Data shown in each panel are from one representative experiment, showing fold-change in cell death 6 SEM in low MOI and high MOI-
infected macrophage supernatants (shaded bars, infection + and ++, respectively) relative to uninfected control (closed bars), from incubations
performed in triplicate. Each experiment was repeated a minimum of three times. **= p,0.01, ***= p,0.001, Student’s t test relative to uninfected
control.
doi:10.1371/journal.pone.0038488.g006
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11.2960.10% death occurred in cells incubated in uninfected
macrophage supernatants. This increased significantly (p,0.001)
to 17.7960.38% and 20.6360.45% in cells incubated in low and
high MOI-infected macrophage supernatants. This cytotoxicity
was not inhibited by coincubation with anti-hTNF-a; cell death
increased significantly from 10.7260.63% in the uninfected
supernatants up to 17.1360.13% and 19.1860.51% (p,0.001
in both cases) in low and high MOI-infected macrophage
supernatants, respectively (fig. 5B). In positive controls, 5 ng/ml
recombinant human TNF-a +0.2 mg/ml cycloheximide caused
26.9661.82% cell death in Jurkats incubated in the presence of
isotype control IgG, which was significantly (p,0.01) reduced to
12.2260.23% in the presence of anti-hTNF-a (fig. 5D).
Anti-Fas blocking antibody, or isotype control IgG were added
at a concentration of 2.5 mg/ml to supernatants. Cell death
increased significantly from 6.1660.65% in uninfected macro-
phage supernatants up to 21.4460.12% (p,0.001) in low MOI,
and 23.0360.38% (p,0.001) in high MOI-infected macrophage
supernatants in the presence of isotype control IgG, and this
pattern was recapitulated in supernatants in the presence of anti-
Fas, where cell death increased from 6.5560.42 in uninfected
supernatants to 21.7961.13% and 25.7060.58% in low and high
MOI-infected supernatants, respectively (p,0.001 in both cases)
(fig. 5C). In positive controls, recombinant human Fas ligand
induced 51.4860.43% cell death, which was significantly reduced
to 34.8460.88% (p,0.001) (fig. 5D).
The Cell Death Signal of Infected Macrophage
Supernatants is Heat-labile and Mediated by Factor(s)
Greater than 50 KiloDaltons in Molecular Size
To investigate the composition of the signalling factor(s) that
induced T cell death, supernatants from uninfected and infected
macrophages were heat-denatured at 95uC for 20 min, and then
applied to Jurkat T cells. Following 24 h incubation, cell death was
measured by Hoechst/PI staining, and expressed as fold-change in
death relative to uninfected control. Unheated supernatants from
low and high MOI-infected macrophages caused a significant
(p,0.01, p,0.001 respectively) fold-increase in cell death to
1.5260.07 and 2.0460.05 of that in the uninfected control
supernatants. This effect was mitigated by heat denaturing; in
Jurkats incubated in heat-treated supernatants, fold-change in cell
death was 0.8860.02 and 1.0160.08 of that in uninfected control
supernatants (fig. 6A).
Subsequently, culture supernatants were passed through 50 kDa
molecular weight cutoff filters, diluted in fresh medium as outlined
in methods, and then used to culture Jurkat T cells. Cell death was
measured by PI/Hoechst staining and expressed as fold-change
relative to the uninfected supernatants. Following 24 h incubation,
death was not increased by the filtrate containing molecules below
50 kDa in size, where low and high MOI supernatant ,50 kDa
fractions at 25% dilution did not induce any significant fold-
change in death compared to that of the control uninfected
supernatant (0.9960.05 and 0.8760.06 fold-change relative to
control, respectively). Conversely, a significant (p,0.001 low
MOI, p,0.01 high MOI) increase was observed in death in cells
incubated in the low and high MOI .50 kDa fractions at 25%
dilution, causing a change of 1.9760.02-fold, and 2.4060.17-fold
respectively, relative to control (fig. 6B). These results were
recapitulated at 10% dilution of the supernatant filtrates and
retentates; again no significant increase in cell death was observed
in T cells cultured in the ,50 kDa fractions of low and high MOI
supernatants (0.9960.05 and 0.8760.06 fold-change relative to
uninfected control), whilst cell death induction was maintained in
the .50 kDa fractions; low MOI supernatant retentate caused a
1.5660.04-fold increase in cell death, whilst high MOI superna-
tant retentate caused a 1.7560.08-fold increase, both of which
were significantly (p,0.001 and p,0.01 respectively) higher than
control (fig. 6B).
Discussion
In our tuberculosis patients, we found that lymphopenia was
prevalent and reversible after treatment for this infectious disease.
This systemic lack of T cell function may be linked to the poor
performance of clinical tests for Mtb infection in tuberculosis
patients that rely on lymphocyte function - such as the Tuberculin
skin test and the Interferon-c release assay. To study the effect of
Mtb-infected macrophages on lymphocyte depletion, we examined
T cell viability when exposed to the cell-free culture supernatant of
infected phagocytes. Our results show that culture supernatants
from Mtb-infected human macrophages induce contact-indepen-
dent T cell apoptosis, in a dose-dependent manner. We found that
T cell survival was unaffected by (macrophage-free) Mtb bacilli or
their secreted products in bacterial culture, with the exception of
ESAT-6, which reliably induced T cell death. However, subse-
quent experiments showed networked T cell death occurred in our
system even when culture supernatants of AMs infected with the
ESAT-6-deficient M.bovis BCG were used. Although T cell death
in macrophage supernatants was caspase-dependent, it was not
mediated by TNF-a or Fas. Further characterisation of the death-
inducing factor(s) revealed them to be heat-labile and greater than
50 kDa in molecular size.
During infection by M.tuberculosis, several strategies facilitate
pathogenesis and avoidance of bacillary destruction, including
perturbation of phagosomal maturation [23], manipulation of
phagocyte viability in order to preserve the replicative environ-
ment and subsequently facilitate release of newly-produced bacilli
[29] and downmodulation of responsiveness to activating signals
[30]. Alteration of host cell signalling responses can also elicit
favourable conditions for Mtb [31], and secreted virulence factors
have also been shown to play a role in modulating immune cell
signalling [32]. Inducing death of host T cells, thereby disrupting
their interaction with infected phagocytes, may be a further
mechanism by which Mtb evades host immunity.
Elimination of immune effector cells in the proximity of infected
phagocytes is thematically consistent with the concept of
establishing the Mtb infection site as an immune-privileged
location [33,34], and it is clear that multiple mechanisms
contribute to this process. Contact-dependent death of nearby,
non-infected cells has been shown in previous studies [14,16,18],
but in our system an additional mode of T cell killing was found,
which was mediated by soluble factors. Other distinct networked
cell signalling effects following Mtb infection are also known to
occur - for example, Green et al. demonstrated that conditioned
medium from infected monocytes elicited release of matrix
metalloproteinase from microglia, representing a novel mechanism
of pathology arising from TB disease in the central nervous system
[35].
Since T cells arriving at the site of infection are likely to be
activated, further investigation is now warranted into the
importance of activation status on Mtb infection- induced cell
death. However, whilst Sharma et al. have shown that activated T
cells undergo increased apoptosis when exposed to Mtb-infected
macrophages [16], our own experiments exposing unstimulated
primary T cells to supernatants from infected macrophages have
also shown increased cell death. It is therefore still unclear to what
degree activation status influences infection-induced networked
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particular subsets of T cells, such as CD4+ or CD8+, would also
be of utility.
Exposure to viable Mtb bacilli did not cause an increase in
T cell death during our coculture experiments, nor did incubation
in their spent culture medium. However, changing physiological
conditions, such as those encountered by Mtb upon phagocytosis
for example, may lead to the expression of a distinct subset of
genes that mediate bacillary survival and persistence [36,37]. Our
model has excluded a role for Mtb bacilli in isolation causing
T cell killing, but virulence factors that are upregulated following
intracellular infection of phagocytes might still contribute to
networked T cell death. We saw that ESAT-6 was sufficient to
cause increased T cell death. However, as mentioned above, it is
unlikely to be the major contributor to death in our system, since
experiments demonstrated the apoptosis-inducing effects of
supernatants from BCG-infected macrophages. BCG does not
express ESAT-6 due to deletion of the RD1 locus [38]. In
addition, our molecular weight separation experiments show that
the proapoptotic signals are mediated by infected macrophage
supernatant factors greater than 50 kDa in size. Although ESAT-6
may be present in .50 kDa complexes with other Mtb virulence
factors [39,40], it is still unlikely to be the death factor in our
presented experiments using Mtb H37Ra. This is because H37Ra
does not secrete abundant ESAT-6 due to a S219L point mutation
in the predicted DNA binding region of the regulator PhoP [41].
TNF-a and Fas/Fas Ligand interactions have both been shown
to regulate cell death during mycobacterial infections [17]. Key
studies by Sharma et al., and Hirsch et al., had previously
implicated TNF-a and Fas in deletion of T cells during Mtb
infection in a contact-dependent manner [16] and in a mixed
PBMC-Mtb coincubation system [15], respectively. The latter
implicated TNF-a, TGF-b, Fas and modulation of Bcl-2
expression in mediating changes in T cell viability in Mtb
infection, but also showed that the mechanisms varied between
patients. When specifically interrogating the effects of soluble
mediators in our own supernatant transfer model, we found that
the addition of blocking antibodies against either TNF-a or Fas to
the infected macrophage supernatants did not reduce killing of
T cells. It is therefore clear that an additional TNF-a- and Fas-
independent mode of action may exist, that is contact-indepen-
dent, and can cause T cells to undergo apoptosis, mediated
exclusively by soluble factors released from infected phagocytes.
Heat treatment showed that the signal(s) present in infected
macrophage supernatants responsible for T cell killing were heat-
labile, and we subsequently employed a molecular size separation
protocol in order to more clearly delineate these factor(s). In these
experiments, the cytotoxic effect separated to the .50 kDa
fraction, and suggested that a large protein or multimeric cytokines
could be responsible. The lack of increased death in cells
incubated in the ,50 kDa fraction indicated that small molecule
mediators such as nitric oxide [42] or ATP [43], though both
relevant in control of tuberculosis infection in macrophages [7,44],
are not responsible for the T cell death observed in our
experimental system. Furthermore, T cell killing activity of
infected supernatants was retained even when the .50 kDa
fractions were diluted to 10% in fresh medium, precluding the
possibility that simple nutrient depletion within the supernatants
was responsible for the cytotoxic effect.
Networked T cell death by soluble host- and/or pathogen-
derived mediators released during Mtb infection may contribute to
the T cell lymphopenia observed in patients with active TB
disease; furthermore, premature deletion of T cells as they
approach the infection site could inhibit the delivery of activating
cytokines such as IFN-c, thus rendering the infected phagocytes
incompetent to degrade and clear the pathogen. A similar mode of
infection-induced networked death signalling occurs during
infection by other intracellular bacteria such as Chlamydia
trachomatis [45]. In the case of M.tuberculosis, this phenotype likely
represents one of several manipulations of host immunity that
enable persistence. It is possible that by protecting T cells from this
toxic influence of infected macrophages in-vivo, the balance may be
tipped towards preserving immune effector capacity, and im-
proved disease resolution.
Supporting Information
Figure S1 Automated cell death image analysis. Images
were acquired at 106magnification using 360/460 nm and 535/
620 nm excitation/emission filter sets to detect fluorescence from
Hoechst and PI staining, respectively (A; bar 50 mm, Hoechst/PI
intensity shown for the same field of view for Jurkat T cells
incubated in control uninfected macrophage supernatant). Normal
nuclei were distinguishable from condensed nuclei (example arrow
1), whilst mitotic cells did not show increased Hoechst staining,
thus precluding false-positives (arrow 2). PI staining was also
clearly distinguishable (arrow 3). Intensity measurements for
Hoechst and PI in each cell were analysed on a cell-by-cell basis;
cells with condensed nuclei were identified by an elevated
coefficient of variance of nuclear intensity (nuclear intensity CV;
a measure of the degree of variation above the nuclear intensities
of other cells in that field) above a user-defined threshold, and PI-
positivity was also identified by intensity above a user-defined
threshold. Using a decision-tree protocol, cells were categorised
into four classes: Live, PI-positive, condensed nucleus, and
condensed nucleus + PI. The latter three categories were then
summed to give percentage cell death for each field of view (B). 12
fields of view were acquired per treatment, and each treatment
was performed in triplicate.
(TIF)
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